Cramer Loves These Dividend Stocks

Jim Cramer, the charismatic host of CNBC’s Mad Money, has become a household name for investors seeking bold, actionable ...
Hosted on MSN

CVS Caremark facing class action suit for dropping coverage of Lilly's Zepbound

A class action lawsuit has been filed against CVS Caremark (NYSE:CVS), the pharmacy benefit manager for health insurer Aetna, after it dropped Eli Lilly's (NYSE:LLY) weight loss med Zepbound ...
NBC Los Angeles

CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans

CVS Health on Thursday said it will significantly expand access to the blockbuster weight loss drug Wegovy for patients covered by its pharmacy benefit manager, Caremark. Stream Los Angeles News for ...

Eli Lilly to spend $6B on AL plant for next-gen drugs. What to know

Eli Lilly is investing $6B in a Huntsville, Ala., plant to make weight-loss and other medicines. Here’s what we know about ...